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Abstract This review assesses the importance of pro-
teostasis in skeletal muscle maintenance with a specific
emphasis on autophagy. Skeletal muscle appears to be
particularly vulnerable to genetic defects in basal and
induced autophagy, indicating that autophagy is co-sub-
stantial to skeletal muscle maintenance and adaptation. We
discuss emerging evidence that tension-induced protein
unfolding may act as a direct link between mechanical
stress and autophagic pathways. Mechanistic links between
protein damage, autophagy and muscle hypertrophy, which
is also induced by mechanical stress, are still poorly
understood. However, some mouse models of muscle dis-
ease show ameliorated symptoms upon effective targeting
of basal autophagy. These findings highlight the impor-
tance of autophagy as therapeutic target and suggest that
elucidating connections between protein unfolding and
mTOR-dependent or mTOR-independent hypertrophic
responses is likely to reveal specific therapeutic windows
for the treatment of muscle wasting disorders.
Introduction
Skeletal muscle functions as both an essential force-gen-
erating tissue and the body’s primary protein reservoir. As
such, it has evolved the plasticity necessary to adapt itself
according to the mechanical and metabolic demands placed
upon it, within the context of the physiological needs of the
whole organism.
Mechanosensitive adaptations in skeletal muscle are
broadly determined by the relative balance between
hypertrophic mTOR signalling and pro-degradation AMPK
signalling. The mTOR pathway is activated by mechanical
tension (Baar et al. 1999, 2000). The activation of mTOR
leads to an increase of protein synthesis for up to 72 h
above rest (Miller et al. 2005) and this positive net balance
leads to muscle fibre hypertrophy of mainly type 2 fibres.
In contrast, inhibition of mTOR with rapamycin prevents
an increase in protein synthesis and compensatory hyper-
trophy in rodents and humans (Bodine et al. 2001; Drum-
mond et al. 2009). Activation of mTOR hence appears to
be a necessary contributing factor (e.g. Frey et al. 2014) for
load-induced muscle growth, but the actual mechanosensor
or mechanotransduction mechanisms remain elusive.
Conversely, when muscle is unused, AMPK inhibits the
mTOR pathway. This results in the upregulation of the two
major proteolytic pathways, autophagy and the Ubiquitin
Proteasome System (UPS), via the FOXO transcription
factors and leads to muscle atrophy. These proteolytic
pathways are also upregulated in response to low avail-
ability of amino acids and other nutrients (Milan et al.
2015; Sandri et al. 2004; Stitt et al. 2004).
Functional degradative pathways are required for atro-
phy and muscle maintenance. Muscle protein synthesis also
relies on the availability of free amino acids, which are at
least in part obtained via the breakdown of old and
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damaged proteins and organelles (see Schiaffino et al. 2013
for a review). Atrophy relies on degradative pathways as
primary effectors. In addition, muscle maintenance relies
on a baseline turnover of mechanically unfolded proteins to
prevent cytotoxic accumulation of aggregates, as well as
the turnover of damaged organelles, particularly
mitochondria.
In this review, we discuss the importance of autophagy
in skeletal muscle with a particular emphasis on the genetic
evidence showing the sensitivity of muscle tissue to
mutations that disrupt basal and induced autophagy path-
ways. We also discuss emerging evidence of a form of
tension-induced autophagy that links degradation of
unfolded protein with the synthesis of its replacement.
Given damage to proteins and organelles correlates to
muscle usage, it is possible that the relative activation of
specific autophagy pathways itself acts as one of the
mechanosensing mechanisms required for muscle
hypertrophy.
Review
Protein turnover in muscle disease
The two major proteolytic systems in skeletal muscle are
the autophagosome/lysosome and the UPS. The importance
of protein turnover in muscle maintenance can be assessed
by quantifying how well represented proteostasis regula-
tion, defined as factors involved in autophagy and the
proteasome, is amongst genetic diseases in muscle. This
could be gathered by a straightforward bioinformatics
analysis of GO terms and cellular components that are
overrepresented in the current list of genes underlying
neuromuscular disorders (Kaplan and Hamroun 2014). An
updated list of muscle disease genes (Kaplan and Hamroun
2014), extended with genes known to cause muscle
pathology when targeted in mice but so far lacking an
associated human disease (from MGI, http://www.infor
matics.jax.org/), was submitted to the software package
GOrilla (Eden et al. 2009) using the reviewed Homo
sapiens UniProt protein list as reference (http://www.uni
prot.org/uniprot).
As expected, many categories of specific cellular pro-
cesses and cellular components are enriched in the disease
list at p values below the threshold of significance.
Autophagy and the autophagosome emerged as signifi-
cantly enriched GO term categories for cellular processes
and components, respectively, whilst the UPS did not [see
Table 1; full input list and output lists of enriched GO
terms for cellular processes and components with the cor-
rected p values for multiple testing (Benjamini and Hoch-
berg 1995) are shown as supplementary material]. This
suggests that muscle maintenance mechanisms are more
susceptible to pathogenic mutations in autophagy than in
the UPS. This evaluation appears likely to under-report the
significance of autophagy in skeletal muscle, as many of
the disease genes shown to cause autophagy disruption
described below did not emerge in the GO term analysis,
e.g. BAG3, MTM1 and VMA21. It is clear that for many
disease genes the corresponding GO terms do not fully
capture their known functions.
Autophagy in skeletal muscle maintenance
Three major autophagic pathways are distinguished
according to how cargo enters the lysosomes: chaperone-
mediated autophagy (CMA), microautophagy and
macroautophagy. In CMA, proteins with the KFERQ
pentapeptide motif in their sequence, typically exposed by
unfolding or denaturing, are recognized by molecular
chaperones and directly translocated into lysosomes
through the LAMP2A (Lysosomal-associated membrane-2
protein) receptor on the lysosomal membrane (Dice 1990).
In microautophagy, cytoplasmic components are directly
engulfed into the lysosomal lumen. And in macroau-
tophagy, a purpose-built double membrane structure sur-
rounds the cytoplasmic components to form the
autophagosome (Mizushima et al. 2008). Autophagosomes
then fuse with the lysosome, and the membrane and con-
tent of the autophagosome vesicle are degraded.
Macroautophagy, commonly and hereafter referred to as
autophagy, is induced by starvation and functions to supply
amino acids and energy from the bulk degradation and
recycling of intracellular components (Klionsky 2007).
It would be expected that autophagy plays a major role
in skeletal muscle, as this constitutes the major reservoir of
protein and energy in the organism. Indeed, fast-twitching
muscles in particular have been shown to be extremely
responsive to starvation-induced autophagy in comparison
to other tissues, including brain (Mizushima et al. 2004).
Moreover, several studies indicate that basal autophagy
levels vary amongst the different muscle types, likely
reflecting their specific physiological demands. Basal
autophagy continuously clears out misfolded proteins,
protein aggregates and worn-out organelles such as mito-
chondria during non-starvation conditions. Muscles expe-
riencing continuous tension may therefore be expected to
have a higher level of basal autophagy as an adaptation to
the presumptive increase in protein unfolding and meta-
bolic strain. Indeed, it has been shown that the expression
of autophagy (LC3-I/LC3-II, Beclin-1 and Atg7) and
mitophagy (BCL-2/adenovirus E1B–interacting protein-3,
abbreviated as Bnip3) proteins is significantly higher in
tonic, oxidative muscle (soleus) when compared to a
muscle of mixed fibre types (plantaris) or a phasic,
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glycolytic muscle (vastus lateralis) (Lira et al. 2013). This
study concluded that oxidative muscles have a higher
autophagic flux, with increased LC3-II/LC3-I ratios and
lack of p62 (also known as SQSTM1) accumulation,
indicating elevated autophagosome turnover. The data
underlying this conclusion are supported by the relative
levels of LC3-II and p62 protein and mRNA in oxidative
and glycolytic muscles of the control group in a different
study (Mofarrahi et al. 2013) and the reports agree that
highly oxidative muscles have higher levels of Bnip3 and
other mitophagy proteins.
A criticism of (Lira et al. 2013) is that their study rep-
resents an indirect way of estimating autophagic flux,
generating interpretations from a snapshot of the relative
levels of autophagy markers. It has been argued that flux is
better measured directly by examining tissue response to
autophagy inhibitors, e.g. colchicine (Mofarrahi et al.
2013) and such approaches are considered more robust in
published guidelines for interpreting autophagy assays
(Klionsky et al. 2016).The effect of such inhibitors is to
prevent the degradation of LC3-II, and measuring the
resulting accumulation thus provides a dynamic measure of
LC3-II synthesis rates. A study using this approach con-
cluded that glycolytic muscles have higher autophagic flux
(Mofarrahi et al. 2013), contradicting the interpretations in
(Lira et al. 2013). However, this approach may not be
suitable in the context of examining the relative baseline
autophagy levels between muscle types given that blocking
autophagy itself is likely to induce aberrant signalling
responses in muscle tissues, particularly with prolonged
colchicine treatments. A recent study in macrophages has
proposed that colchicine functions to activate AMPK by
promoting phosphorylation of LKB1 (Wang et al. 2016).
Since fast-twitch muscles are more sensitive to the induc-
tion of autophagy, possibly due to higher levels of Ulk1
protein allowing rapid activation of LC3-II biosynthesis
(Mizushima et al. 2004; Mofarrahi et al. 2013), the use of
colchicine is likely to overestimate genuine basal flux in
fast-twitch muscles. Shorter treatments with leupeptin are
used to provide similar flux measurements. These are likely
to be more robust than those obtained using colchicine, but
the question of how well tissues with varying sensitivities
to autophagy induction can be compared via this method
remains unclear. Until this bias can be controlled for,
estimation of flux using snapshots of autophagy markers
may represent the more reliable way of comparing basal
autophagy between muscle types.
Beyond basal- and starvation-induced autophagy, the
accumulation of misfolded proteins that results from
cytoskeletal stress induces a specific form of autophagy
known as Chaperone-Assisted Selective Autophagy
(CASA). As discussed later, CASA has been shown to be
particularly relevant for tension bearing cells where it
targets specific proteins for degradation such as filamin C
(FLNC) (Arndt et al. 2010; Ulbricht et al. 2013). Disrup-
tion of autophagy in LAMP-2 knockout mice leads to
progressive muscle weakness but, intriguingly, accumula-
tion of aggregated FLNC as well as accumulation of
autophagic vacuoles have been reported only in soleus
muscle (Arndt et al. 2010; Tanaka et al. 2000). This may
indicate that the efficient turnover of structural proteins is
more critical in tonically active muscle.
Disruption of autophagy induces skeletal muscle
pathology
Genetic defects that disrupt each of the phases that
autophagy encompasses (initiation, maturation and degra-
dation of the lysosomal autophagic content) underlie
skeletal muscle disease in mice and humans (Fig. 1).
Moreover, the severity of the phenotype may depend on
whether the mutation alters basal or an inducible form of
autophagy.
In mice, activation of autophagy can be detected just
15 min after acute exercise (He et al. 2012). This rapid
activation is underpinned by the disruption of the BCL2–
Beclin-1 complex in the endoplasmic reticulum (ER)
(Pattingre et al. 2005). Beclin-1 is involved in autophagic
Table 1 Selected GO term categories overrepresented in muscle disease genes
Description Category GO term p value FDR q-value Contributing genes
Z-disc Component GO:0030018 8.26E-41 6.67E-38 CAPN3, KCNA5, CSRP3, ACTN2, CRYAB, JUP, MYH6,
MYH7, CASQ2, MYOZ2, BAG3, FLNC, PSEN2, SMN1,
SCN5A, TCAP, CACNA1C, MURC, SCN8A, LDB3, RYR2,
BIN1, SCN3B, CAV3, JPH2, TTN, NEB, DMD, KCNE1,
DES, HSPB1, SYNE2, NEXN, MYOT, DNAJB6, ANK2,
MYPN
Autophagosome Component GO:0005776 6.26E-05 1.10E-03 PIK3R4, PIK3C3, ORAI1, C9orf72, OPTN, UBQLN2
Autophagy Process GO:0006914 5.62E-04 1.77E-02 PIK3R4, MFN2, PIK3C3, ATG4C, C9orf72, OPTN,
UBQLN2, EPG5
FDR q-value is the false discovery rate correction of the above p value for multiple testing using the Benjamini and Hochberg method (Stitt et al.
2004)
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vesicle nucleation through its interaction with Vps34 (Ki-
hara et al. 2001), a Class III phosphatidylinositol 3-kinase
(PI3K) that converts phosphatidylinositol (PI) to phos-
phatidylinositol 3-phosphate (PI3P). BCL2 inhibits both
the interaction between Beclin-1 and Vps34 and the
Beclin-1-associated Vps34 kinase activity (Pattingre et al.
2005). This inhibitory role of BCL2 is released upon the
phosphorylation of three key residues within the non-
structured loop of the protein (Wei et al. 2008). Mutations
in the BCL2 phosphorylation sites (Thr69Ala, Ser70Ala
and Ser84Ala) prevented exercise-induced disruption of the
BCL2–beclin-1 complex and subsequent activation of
autophagy (He et al. 2012). The BCL2 mutations, referred
to as BCL2 AAA, did not disrupt basal autophagy; yet,
homozygous BCL2 AAA mice not only showed impaired
exercise endurance, but also impaired glucose metabolism
following a regime of chronic exercise and high-fat diet
(He et al. 2012). Maximal running distance in a single
session was also significantly lower in BCL2 AAA mice.
However, other methods of autophagy impairment that
specifically target skeletal muscle have not confirmed that
autophagy is required for an acute bout of exercise or
significant changes in glucose homeostasis. These studies
used either Beclin-1 heterozygous mice, constitutive mus-
cle specific muscle-specific deletion of Atg7 or inducible
muscle-specific deletion of Atg7 (Lira et al. 2013; Kim
et al. 2013; Lo Verso et al. 2014). Atg7 is the E1-like
enzyme of the ubiquitin-like conjugation systems that
activates the E3-like ubiquitin ligase Atg5 to form a
complex with Atg12, which is essential for LC3-1 conju-
gation to phosphatidylethanolamine to form LC3-II
(Tanida et al. 2001). Discrepancies between these experi-
ments may rest on the involvement of other organs in the
case of the constitutive BCL2 AAA mice, the specific gene
Fig. 1 Proteins with known or inferred roles in autophagy that
underlie muscle pathologies in mice and humans. Virtually all stages
of autophagy, including exercise-induction via phosphorylation of
Bcl2, response to sarcomeric protein unfolding via the CASA
pathway as well as autophagosome biosynthesis and maturation are
targets in muscle disease. Positive regulators and components of the
autophagy pathway that are associated with muscle pathology are
shown as protein symbols in green. Negative regulators which are
associated with muscle pathology, as protein symbols in red. In
addition, the downregulation/impairment of autophagy observed in
laminin a2 deficiency, mdx and LmnaH222P/H222P mouse models and
upregulation of autophagy in collagen VI deficiency are indicated
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being targeted or even the length and timing of autophagy
impairment. Indeed, constitutive deletion of Atg7 in
skeletal muscle leads to compensatory upregulation of the
Fg21 mitokine triggered by accumulation of damaged
mitochondria. In turn, Fg21 upregulation promotes effec-
tive protection from high-fat diet-induced obesity and
insulin resistance (Kim et al. 2013), phenotypic outcomes
opposed to those observed in BCL2 AAA mice.
Accumulation of damaged mitochondria is a consis-
tently reported cellular event in autophagy-impaired mus-
cle. In normal muscle, endurance exercise training induces
expression of mitochondrial biogenesis markers (evidenced
by upregulation of CyC, Cox4 and Pgc1-a) and mitophagy
(Bnip3) in mixed fibre type plantaris muscle but not in
oxidative soleus muscle (Lira et al. 2013). Autophagy-
impaired Beclin-1 ± mice, which are haploinsufficient for
the Beclin-1 component of PI3-Kinase complexes involved
in autophagy and protein sorting (Cao and Klionsky 2007),
do not induce upregulation of those mitochondrial turnover
markers. These mice failed to improve endurance capacity
when assessed by maximal treadmill running distance (Lira
et al. 2013). Similarly, dysfunctional mitochondria accu-
mulated in exercised mice in which Atg7 deletion was
induced prior to exercise (Lo Verso et al. 2014). In the
latter, training consisted of consecutive bouts of downhill
running to induce damaging eccentric contraction, which
resulted in decrease in performance in autophagy-impaired
mice. Morphologically abnormal, functionally deficient
swollen mitochondria have also been shown to accumulate
in mice with muscle-specific constitutive deletion of Atg7
(Kim et al. 2013; Masiero et al. 2009; Wu et al. 2009).
Thus, a view has emerged that a main role for exercise-
induced autophagy in skeletal muscle is to remove dam-
aged mitochondria that would otherwise accumulate and
prevent improvement of endurance capacity.
Constitutive impairment of basal autophagy has clear
detrimental effects on skeletal muscle although akin to the
examples above, differences in phenotypic outcomes have
been reported depending on the targeting strategy. For
instance, deletion of Atg7 in skeletal muscle driven from
the creatine kinase promotor or the myosin light chain fast
1 promotor results in degenerative changes from 40 days
(Wu et al. 2009) or longer than one year (Masiero et al.
2009), respectively. The fact that constitutive autophagy is
essential to preserve muscle integrity was also demon-
strated by the phenotypes of Atg5 KO mice, characterized
by muscle loss, protein aggregates and accumulation of
numerous aberrant membranous structures (Kihara et al.
2001). An example of detrimental effects caused by
excessive autophagy is provided by NAF-1, a small
endoplasmic reticulum (ER) transmembrane protein and
cofactor required for BCL2 to antagonize Beclin-depen-
dent autophagy at the ER. Lack of NAF-1 triggered an
excess of autophagy in non-stimulated conditions. Skeletal
muscle, particularly the diaphragm, was amongst the first
tissues to show degeneration (Chang et al. 2012).
Defects in later stages of autophagy also result in major
muscle pathology. The mammalian orthologue of Vps15
was recently knocked out in mice (Nemazanyy et al. 2013).
In yeasts, the Vps15/Vps34 complex is involved in the
delivery of soluble hydrolases from the Golgi to the vac-
uole and is required for endosomal sorting and autophagy
(Schu et al. 1993). Vps15 is a phosphoinositide-3-kinase
adaptor protein that regulates the activity of Vps34.
Though lethal when deleted ubiquitously, muscle-specific
deletion of Vps15 resulted in defects in late endosomal/
lysosomal functions and accumulation of ultrastructural
features reminiscent of lysosomal storage diseases and
autophagic vacuolar myopathy (Nemazanyy et al. 2013).
Autophagy and skeletal muscle disease
In humans, mutations have been identified affecting later
steps in the autophagic process. X-linked myopathy with
excessive autophagy is caused by haploinsufficiency
mutations in the VMA21 gene, which codes for the trans-
membrane subunit of the V-ATPase lysosomal proton
channel (Ramachandran et al. 2009). The reduced activity
of the V-ATPase results in reduced proton influx and an
increase of 0.5 units of the lysosomal pH. This higher pH
caused impaired degradative power of the lysosome and
lower levels of free AAs. The limited AA availability
induced autophagy as a compensatory mechanism through
mTOR, which leads to excessive autophagy. Given that the
pathological findings were restricted to muscle, it was
suggested that skeletal muscle is particularly sensitive to
the upregulation of autophagy. Muscle susceptibility to
autophagic perturbations has indeed been reported in other
inherited conditions. Danon disease is characterized by the
presence of autophagic vacuoles with sarcolemmal features
(Nishino et al. 2000). It is caused by mutations in the major
component of the lysosomal membrane LAMP2. Although
a multisystemic disorder, skeletal muscle and heart are the
most affected tissues in patients (Sugie et al. 2002). In
mice, lack of this structural lysosomal protein also causes
increased postnatal lethality, although some mice survive
and have a normal life span. Mice that survive show
accumulation of autophagosomes in many tissues, but the
prominent pathological manifestations are also found in
heart and skeletal muscle (Tanaka et al. 2000). It appears
clear that LAMP2 is required for phagosome and
autophagosome fusion, but not for proteolytic function of
the lysosome (Eskelinen et al. 2002, 2004).
However, the degradative fitness of the lysosome is also
a target in muscle disease. In Pompe disease, the under-
lying defect is the lysosomal enzyme a-glucosidase (or
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acid maltase), which hydrolyzes glycogen and maltose to
glucose. Pompe described this disease in 1932 when he
observed abnormal accumulation of glycogen in all tissues
examined from an infant that died from idiopathic hyper-
trophic cardiomyopathy. Pompe disease affects multiple
tissues, but skeletal and cardiac muscles are particularly
vulnerable to the accumulation of storage material and the
perturbation of autophagy. Enzyme replacement therapy
(ERT) with recombinant human lysosomal acid a-glu-
cosidase has been trialled in humans with mixed results
(Amalfitano et al. 2001; Klinge et al. 2005; Winkel et al.
2004). Studies in a-glucosidase KO mice suggest that
excessive autophagic buildup, particularly in glycolytic
fibres, underlies muscle damage (Fukuda et al. 2006).
Moreover, this buildup has been hypothesized to prevent
trafficking of replacement enzyme to the lysosomes and
compromise ERT efficacy (Fukuda et al. 2006). This
accumulation of autophagic material at the core of the
fibres is due to impaired autophagosome lysosome fusion,
although induction of autophagy may also contribute
(Raben et al. 2008). Indeed, engineered MLCcre:Atg7F/F:
GAA-/- mice that combine a-glucosidase deficiency and
skeletal muscle-specific impairment of autophagy show
very significant reduction of autophagic buildup and good
response to ERT compared to the lack of clearance of
lysosomal glycogen observed in GAA-/- mice (Raben
et al. 2010). In humans, autophagy impairment manifested
as accumulation of p62-positive aggregates correlates with
atrophy both in infantile and late onset cases of Pompe
disease (Nascimbeni et al. 2012). This study showed that
autophagy acts as a protective mechanism during the early
stages of the disease and may enable ERT efficacy; con-
versely, if excessive autophagic buildup and glycogen are
already present, there is no beneficial response to ERT,
possibly because autophagy is required for delivery of
recombinant GAA to the lysosomes but is irreversibly
compromised (Nascimbeni et al. 2012).
More recently, mutations have been identified in the
ectopic p-granules autophagy protein 5 (EPG5) gene as
causative of VICI syndrome (Cullup et al. 2013). EPG5
deficiency causes an autophagic block, with accumulation
of numerous vacuole-like structures and dense bodies,
possibly of lysosomal origin in skeletal muscle. Although
the molecular function of EPG5 is not known, it appears
crucial for the formation of degradative autolysosomes
(Tian et al. 2010). This appears consistent with accumu-
lation of p62, NBR1 and lipidated LC3-II in patient-
derived fibroblasts, altogether pointing at an autolysosome
clearance defect (Cullup et al. 2013).
A number of muscle diseases have also been reported in
which alterations of autophagy flow contribute to the
pathogenic mechanism. Autophagic signalling has been
shown to be impaired in muscles from dystrophin-deficient
mdx mice and Duchenne muscular dystrophy patients (De
Palma et al. 2012; Pauly et al. 2012; Eghtesad et al. 2011).
Reactivation of autophagy by dietary means, induction of
AMPK activation or rapamycin treatment has been shown
to be effective in ameliorating the dystrophic phenotype in
mdx mice (De Palma et al. 2012). Delivery of rapamycin
via direct intramuscular injections of nanoparticles is par-
ticularly effective in inducing autophagic flux both in wild
type as well as mdx animals (Fig. 4 in Bibee et al. 2014).
The latter study indicates that a role for mTOR-C1 (the
rapamycin sensitive component of mTOR) in inducing
autophagy exists in normal muscle, in contrast to previous
findings showing that rapamycin treatment does not induce
significant LC3 lipidation in skeletal muscle (Fig. S6 in
Mammucari et al. 2007); the authors of this latter study
unconventionally propose that mTOR-C2 rather than
mTOR-C1 is essential for autophagy.
Mutations in the LMNA gene, which encodes lamin A
and C (lamin A/C), cause autosomal Emery–Dreifuss
muscular dystrophy. A mouse model carrying a point
mutation in Lmna (LmnaH222P/H222P) faithfully recapitu-
lates the human disease. LmnaH222P/H222 mice have
enhanced mTORC1 signalling specifically in cardiac and
skeletal muscle. LmnaH222P/H222P mice treated with the
rapamycin analogue temsirolimus exhibit improved cardiac
function with reduced expression of genes associated with
ventricular dilatation relative to those treated with placebo
(Choi et al. 2012). Similar results were obtained with
another lamin-deficient mouse model of Emery–Dreifuss
muscular dystrophy using rapamycin injections (Ramos
et al. 2012). Thus, inhibition of mTORC1 led to significant
amelioration of the cardiac pathology in both cases by
efficient reactivation of autophagy with rapamycin or one
of its analogues.
A number of mutations in mice and humans result in
skeletal muscle pathology with changes in autophagy as a
likely contributing factor. Loss of function mutations in
myotubularins, the lipid phosphatases that specifically
dephosphorylate PI3P and PI(3,5)P2 at the D3 position, has
been associated with defects in the inhibition of autophagy
and myopathy (Fetalvero et al. 2013). These include
mutations in myotubularin 1 (MTM1) and myotubularin-
related protein 14 (MTMR14) that are associated, respec-
tively, with X-linked myotubular myopathy (Laporte et al.
1997) and congenital disease centronuclear myopathy
(Tosch et al. 2006). Mutations in valosin-containing pro-
tein (VCP) cause inclusion body myopathy and Paget
disease of the bone and have been shown to alter
autophagosome maturation and autophagy impairment
(Custer et al. 2010; Tresse et al. 2010). Additional exam-
ples with opposite effects on the levels of autophagy are
provided by mutations in laminin a2 and collagen VI.
Expression of autophagy-related genes is upregulated in
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laminin a2 chain-deficient muscle and, moreover, inhibi-
tion of autophagy significantly improves the dystrophic
phenotype of the mouse model (Carmignac et al. 2011).
Conversely, skeletal muscles of collagen VI–knockout
mice show impaired autophagic flux, lower induction of
beclin-1 and Bnip3 and a lack of autophagosomes after
starvation. Forced activation of autophagy by genetic,
dietary and pharmacological approaches restored myofibre
survival and ameliorated the dystrophic phenotype of the
knockout mice (Grumati et al. 2010). Expression of a
mutant form of SOD1 (SOD1G93A) in mice has also been
shown to cause elevated activation of autophagy due to
increased oxidative stress, resulting in muscle atrophy
(Dobrowolny et al. 2008), and sarcopenia also results from
elevated autophagy (Wenz et al. 2009). Finally, ultra-
structural evidence of autophagy and uncleared inclusions
are present in a mouse model of hereditary inclusion
myopathy (h-IBM), a distal myopathy caused by mutations
in the UDP-N-acetylglucosamine 2-epimerase/N-acetyl-
mannosamine kinase (GNE) gene, which encodes for a
bifunctional enzyme involved in sialic acid biosynthesis
(Malicdan et al. 2007). The underlying mechanisms of
autophagy disruption in these and other examples (Chang
et al. 2012; Bridges et al. 1992; Roos et al. 2014) (see also
Table 2) remain largely unknown, but the panoply of
mutations in mice and humans summarized here indicate
that muscle is particularly vulnerable to the dysregulation
of autophagy.
Mechanical stress and proteostasis
It appears clear that autophagy is important for short- and
long-term muscle adaptations to mechanical stress (He
et al. 2012). Both the application and absence of mechan-
ical stress in muscle result in a requirement to increase
protein degradation. The application of mechanical stimuli
results in elevated levels of unfolded protein, which must
be cleared efficiently to prevent cell stress, toxicity and the
formation of disruptive aggregates. As described below,
prolonged paralysis evokes an adaptive increase in protein
degradation that results in net disassembly of sarcomeric
structures and whole muscle atrophy.
A key set of proteins in the activation of degradative
pathways are the FOXO transcription factors (reviewed in
Milan et al. 2015). These were identified as the primary
contributor to upregulation of atrogene expression in
skeletal muscle in atrophic conditions, as well as activation
of autophagy pathways (Sandri et al. 2004; Mammucari
et al. 2007). The FOXO transcription factors are suppressed
by phosphorylation via AKT signalling (Stitt et al. 2004),
and activated via HDAC1 in conditions which suppress
AKT activity, such as limb suspension (Beharry et al.
2014).
Given the coordinate regulation of both degradative
pathways, it would appear that both autophagy and UPS
have a role in skeletal muscle adaptation during atrophy,
though the relative importance of each pathway remains
unclear. A study in a myoblast cell line showed that
FOXO-induced autophagy substantially contributed to
proteolysis in atrophy-inducing conditions (Zhao et al.
2007), though how well this translates in vivo has yet to be
established.
The balance of evidence suggests that the UPS has a
more critical role in adaptive atrophy, which is associated
with elevated proteasome activity (Medina et al. 1991),
upregulation of proteasome-encoding mRNA (Medina
et al. 1995) and upregulation of the E3 ubiquitin ligases
MuRF1, MAFbx (Bodine et al. 2001) and the recently
identified SMART (Milan et al. 2015). Inhibition of the
proteasome protects from starvation- (Caron et al. 2011)
and denervation (Beehler et al. 2006)-induced atrophy. In
contrast, inhibition of autophagy has been demonstrated to
itself result in atrophy (Masiero et al. 2009; Masiero and
Sandri 2010), but this is likely a secondary effect of dis-
rupted muscle maintenance, with accumulation of damaged
proteins and organelles impacting on tissue growth, a dis-
tinct mechanism from regulated atrophy. Given that inhi-
bition of autophagy fails to protect from atrophy (Masiero
et al. 2009), autophagy appears less likely to have a major
role in adaptive atrophy.
Though there is some degree of upregulation of pro-
teasomal subunit activity in mechanical overloading
experiments (Baehr et al. 2014), the correlation between
mechanical stress and autophagy is more established.
Autophagy is elevated for around 24 h after exercise
(Moller et al. 2015). Moreover, baseline levels of autop-
hagy rise in adaptation to repeated bouts of exercise (Lira
et al. 2013; Grumati et al. 2010; Ulbricht et al. 2015).
Presumably, the former is a mechanism to aid clearance of
damaged proteins and organelles immediately after
mechanical stress, and the latter the mechanism required to
couple higher protein turnover to continued protein
unfolding.
The mechanistic link between mechanical stimuli and
autophagy remains poorly defined, but there is strong evi-
dence that the BAG (Bcl2-associated athanogene) proteins
are involved in the adaptation of proteostasis. BAG pro-
teins have multiple domains and are known to modulate a
number of cellular processes (Kabbage and Dickman 2008)
including the chaperone activity of heat shock protein
Hsc70 (Brive et al. 2001). In the context of proteostasis,
complexes containing BAG1 favour degradation via UPS,
whereas complexes involving BAG3 favour degradation
via autophagy (Behl 2011). This ‘‘molecular switch’’ from
BAG1 to BAG3 signalling prominence has been proposed
to mediate adaptive upregulation of autophagy during
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ageing and cell stress (Behl 2011; Minoia et al. 2014). It is
likely that this mechanism is relevant to immediate repair
and longer-term adaptation in muscle. Indeed, BAG3
expression is increased in tension, under the regulation of
Heat Shock Factor 1 (HSF1) (Ulbricht et al. 2013) but
whether the reciprocal expression of BAG1 and BAG3
seen in ageing exists in the skeletal muscle mechan-
otransduction context has yet to be explored. However, a
recent study has demonstrated that BAG3 has a higher
affinity than BAG1 for co-chaperones (Rauch and Gest-
wicki 2014), thus upregulation of BAG3 alone may fulfil
the role of the molecular switch towards autophagy.
The question of why upregulation of autophagy, and not
UPS, might be favoured in this context is likely one of
efficiency. Whilst the relative energetic cost of autophagy
and the UPS for equivalent clients remains unknown, evi-
dence suggests that autophagy is better able to clear
aggregates, as demonstrated in certain pathological models
(Rodriguez-Navarro et al. 2010; Ruparelia et al. 2014;
Schaeffer et al. 2012) and is certainly better able to turn
over damaged or faulty organelles.
The Z-disc integrates autophagic and hypertrophic
pathways
Tension-induced growth signalling is by no means limited
to proteins at the z-disc. For example, the kinase domain of
titin has been proposed to induce elevated protein synthesis
when activated by tension. The conformational change
promotes activation of Neighbour of BRACA1 gene 1
(NBR1), which recruits p62 to the sarcomere. This facili-
tates MuRF2 activation of serum response factor (SRF),
which is translocated to the nucleus to promote transcrip-
tion (Lange et al. 2005). NBR1 also interacts with LC3-I
Table 2 Genes associated with skeletal muscle pathology with evidence of autophagy disruption
Gene Disease/model Evidence of autophagy disruption References
VMA21 X-linked myopathy with excessive
autophagy (XMEA)
Reduced lysosomal proton influx Ramachandran et al. (2009)
LAMP2 Danon disease Autophagosome accumulation Tanaka et al. (2000), Nishino et al.
(2000)
GAA Pompe disease Impaired autophagosome–lysosome fusion Amalfitano et al. (2001)
EPG5 VICI syndrome Autolysosome clearance defect Cullup et al. (2013)
MDX Duchenne muscular dystrophy Impaired autophagy signalling De Palma et al. (2012)
LMNA Emery–Dreifuss muscular dystrophy Enhanced mTORC1 signalling resulting in
inhibited autophagy
Choi et al. (2012)
MTM1 X-linked tubular myopathy Defects in autophagy inhibition Fetalvero et al. (2013)
MTMR14 Congenital disease centronuclear
myopathy
Defects in autophagy inhibition Fetalvero et al. (2013), Tosch et al.
(2006)
VCP Inclusion body myopathy Altered autophagosome maturation Custer et al. (2010)
LAMA2 Mouse model Constitutive upregulation of autophagy genes Carmignac et al. (2011)
COL6A Mouse model Impaired autophagy induction and flux Grumati et al. (2010)
GNE Hereditary inclusion myopathy Ultrastructural evidence of autophagy and
uncleared inclusions
Malicdan et al. (2007)
KY Hereditary kyphoscoliosis Ultrastructural evidence of autophagy Bridges et al. (1992)
SIL1 Marinesco–Sjogren syndrome Impaired autophagic clearance Roos et al. (2014)
SOD1 Mouse model Elevated oxidative stress resulting in
constitutively elevated autophagy
Dobrowolny et al. (2008)
DNAJB6 Limb girdle muscular dystrophy Loss of autophagy co-chaperone Sarparanta et al. (2012)
BAG3 Mouse model of fulminant myopathy Central chaperone to Chaperone-Assisted
Selective Autophagy
Arndt et al. (2010), Homma et al.
(2006)
ATG7 Inducible deletion/muscle-specific
deletion
Accumulation of dysfunctional mitochondria Lira et al. (2013), Kim et al. (2013),
Masiero et al. (2009)
BCL2 Mouse knock-in Prevention of exercise-induced autophagy He et al. (2012)
BECN1 Haploinsufficient mouse model Impaired upregulation of autophagy Lira et al. (2013)
CISD2
(NAF-1)
Mouse model of Wolfram syndrome 2 Enhanced basal autophagy Chang et al. (2012)
VPS15 Autophagic vacuolar myopathy Defects in late endosomal/lysosomal functions Nemazanyy et al. (2013)
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and polyubiquitin chains, suggesting a link to protein
turnover (Waters et al. 2009; Kirkin et al. 2009). As pre-
viously discussed, NBR1 puncta are observed in the mus-
cles of VICI syndrome patients (Cullup et al. 2013).
However, although a mutation in titin disrupting nbr1
interactions with the kinase domain of titin is associated
with a muscular disorder (Lange et al. 2005), there are no
specific models of NBR1 disruption with an overt muscle
phenotype.
The Z-disc arose as the secondmost significantly enriched
cellular component amongstmuscle disease genes (Table 1).
The Z-disc lies in series with the force-generating sarcom-
eres and experiences force directly, being therefore ideally
placed to include triggers of hypertrophy upstream of the
mTOR pathway, particularly in light of the increasing evi-
dence that the mTOR pathway is distinctively activated by
growth factors and mechanical stimulation (Miyazaki et al.
2011). Mutations underlying cardiac and/or myopathic dis-
orders suggest that the Z-disc is also a mediator of muscle
adaptation. For example, mutations in the Z-disc associated
proteins T-cap, Myozenin-2, ZASP, myotilin, Filamin C,
alpha–beta-crystallin, BAG3, FHL1, DNAJB6, alpha 2
actinin, desmin orKY provoke hypertrophy of the ventricular
walls, dilated cardiomyopathy or skeletal muscle disorders
(Blanco et al. 2001; Goldfarb et al. 1998; Hauser et al. 2000;
Mohapatra et al. 2003; Moreira et al. 2000; Osio et al. 2007;
Sarparanta et al. 2012; Schessl et al. 2008; Selcen et al. 2009;
Vatta et al. 2003; Vicart et al. 1998; Vorgerd et al. 2005).
These various pathologies reflect the functional impairment
of the protein, but the fact that some mutations cause dys-
regulation of growth control in the heart has led to the current
predominant view that signalling hubs formechanosensation
and mechanotransduction, amongst other locations such as
the M-band or costameres (Gehmlich et al. 2008), must also
reside at the Z-disc (Frank and Frey 2011; Frank et al. 2006).
Despite the strong genetic evidence, the underlying mecha-
nisms translating Z-disc based cytoskeletal stresses into gene
expression remain poorly defined.
A tension-induced form of client-specific autophagy,
CASA, has been recently described. CASA plays a major
role in tension bearing cells and is required for muscle
maintenance (Arndt et al. 2010; Ulbricht et al. 2013). The
strain-provoked irreversible unfolding of the Z-disc and
actin crosslinker protein filamin C (FLNC) is proposed to
be the trigger of CASA. The chaperones HSC70 and
HSPB8 bind to unfolded FLNC and form a complex with
BAG3 that likely assists in releasing damaged FLNC from
the Z-disc. FLNC is then ubiquitinated and complexed with
autophagosome membrane precursors and degraded upon
lysosomal fusion. Intriguingly, as discussed previously,
mechanical tension also upregulates BAG3, making BAG3
available for interaction with components of the Hippo
pathway. In particular, BAG3 interacts with inhibitors of
the YAP/TAZ transcription factors via its WW domains,
effectively releasing YAP/TAZ from its inhibitors. YAP/
TAZ can then translocate to the nucleus and upregulate the
synthesis of target genes involved in cytoskeleton remod-
elling (Morikawa et al. 2015), including FLNC. This dual
role of BAG3 enables CASA to deal with mechanical stress
whilst maintaining the correct balance of functional pro-
tein, by adapting turnover rates of FLNC to tension con-
ditions (Ulbricht et al. 2013).
Although CASA components are upregulated in stressed
muscle (Ulbricht et al. 2015), the CASA mechanism has
been elucidated primarily in smooth muscle cells (Ulbricht
et al. 2013). Extrapolation of CASA to sarcomeric cells is
plausible, but the overall importance of CASA as sensor
and mediator of cytoskeletal stresses in skeletal muscle is
likely to rest on the identification of additional skeletal
muscle-specific clients. The importance of CASA in mus-
cle maintenance stems from Z-disc defects of BAG3
mutants in mammals and Drosophila. However, the Z-disc
disorganization and other myopathic changes observed in
the mouse BAG3 knockout (Homma et al. 2006) may at
least be partially attributed to a structural role of BAG3
distinct from its co-chaperone function in CASA, as sug-
gested by other evidence (Hishiya et al. 2010).
Conclusions
Although key details remain to be addressed, autophagy is
co-substantial to skeletal muscle maintenance and adapta-
tion and has already been targeted to ameliorate disease
(Raben et al. 2010; Carmignac et al. 2011; Grumati et al.
2010, 2011 Bhuiyan et al. 2013; Cabet et al. 2015; Chrisam
et al. 2015;Hidvegi et al. 2015;Hsueh et al. 2016;Whitehead
et al. 2015; Foltz et al. 2016). A greater understanding of
tension-induced autophagy systems may help to elucidate
connections between protein unfolding and mTOR-depen-
dent or mTOR-independent hypertrophic responses. This is
likely to reveal new and more specific therapeutic windows
for the treatment of muscle wasting disorders.
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